TrialInternational journal of radiation oncology, biology, physics2025

A Phase 2 Study of Multiparametric Magnetic Resonance Imaging-Guided High-Dose Response-Adaptive Radiation Therapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma: Results From an Interim Analysis.

Michelle M Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.